CEL-SCI Corp (CVM) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $4.56
• Market Cap: $36.91M
• EPS: $-6.27
• 52-Week High: $13.48
• 52-Week Low: $1.98

Market Sentiment

CEL-SCI Corp currently has a Neutral sentiment score of 0.02.

About CEL-SCI Corp

CEL-SCI Corporation (CVM) is an innovative biotechnology company focused on advancing immunotherapy solutions for cancer and infectious diseases. Based in Vienna, Virginia, the company is dedicated to developing its lead product candidate, Multikine, which aims to harness the body's immune system to target and destroy tumors. With a robust pipeline and commitment to addressing unmet medical needs, CEL-SCI is positioned to make significant contributions to the field of cancer treatment and bey...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for CEL-SCI Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CVM pay dividends?

CEL-SCI Corp (CVM) does not currently pay a regular dividend.

What is CVM's market cap?

CEL-SCI Corp (CVM) has a market capitalization of $36.91M with a current stock price of $4.56.